While the US healthcare system has come under fire for its lack of openness,[19] new legislation may encourage greater openness. There is a perceived tension between the need for transparency on the one hand and such issues as patient confidentiality and the possible exploitation of information for commercial gain on https://cashjszgm.tdlwiki.com/1002369/arzneimittelinformationen_eine_Übersicht